The 65 references in paper A. Essaian M., А. Есаян М. (2008) “ЭССЕНЦИАЛЬНАЯ ГИПЕРТЕНЗИЯ С НЕФРОПАТИЕЙ. НАСКОЛЬКО ЭТО АКТУАЛЬНО В НАШИ ДНИ? // ESSENTIAL HYPERTENSION WITH NEPHROPATHY, HOW ACTUAL IS IT NOWADAYS?” / spz:neicon:nefr:y:2008:i:2:p:16-22

1
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардио­ ренальный континуум: патогенетические основы превентив­ ной нефрологии. Нефрология 2005; 9 (3): 7-14
(check this in PDF content)
2
Есаян АМ. Антигипертензивная терапия и прогрес­ сирование почечной недостаточности. Consilium Medicum 2001; (10): 38-43
(check this in PDF content)
3
Caetano ERSP, Zatz R, Saldanha LB, Praxedes JN. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 2001; 38: 171-176
(check this in PDF content)
4
Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 2003; 41: 1-12
(check this in PDF content)
5
Chobanian A, Bakris GL, Black HR et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572
(check this in PDF content)
6
United States Renal Data System. USRDS 2000 Annual Data Report 2000
(check this in PDF content)
7
Perry HM Jr, Miller JP, Fornoff JR et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995; 25: 587-594
(check this in PDF content)
8
MacMahon S, Cutler JA, Stamler J. Antihypertensive drug treatment: potential, expected and observed effects on stroke and on coronary heart disease. Hypertension 1989; 13 [Suppl 1]: 45-50
(check this in PDF content)
9
National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on hypertension and chronic renal failure. Arch Intern Med 1991; 151: 1280-1287
(check this in PDF content)
10
Mazzuchi N, Schwedt E, Fernandez JM et al. Latin American Registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Daial Transplant 1997; 12: 2521-2527
(check this in PDF content)
11
Ministry of Health. Assistance to patients with chronic renal disease. Brasilia, Brazil 1997.
(check this in PDF content)
12
DAmico G. Comparability of different registries of renal replacement therapy. Am J Kidney Dis 1995; 25 (1): 113-118
(check this in PDF content)
13
Agodoa LY, Eggers PW. Renal replacement therapy in the United States: data from United States Renal Data System. Am J Kidney Dis 1995; 25: 119-133
(check this in PDF content)
14
Бикбов БТ, Томилина НА. О состоянии заместитель­ ной терапии больных с хронической почечной недостаточ­ ностью в Российской Федерации в 1998-2003 гг Нефрология и диализ 2005; (3): 204-265
(check this in PDF content)
15
Volhard F, Fahr T. Die Bright’sche Nierenkrankheit. Berlin, Julius Springer Verlag 1914
(check this in PDF content)
16
Perera GA. Hypertensive vascular disease; description and natural history. J Chronic Dis 1955; 1: 33-42
(check this in PDF content)
17
Beevers DG, Lip GY. Does non-malignant essential hypertension cause renal damage? A clinician’s view. J Hum Hypertens 1996; 10: 695-699
(check this in PDF content)
18
Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18
(check this in PDF content)
19
Iseki K. The Okinawa Screening Program. J Am Soc Nephrol 2003; 14 (Suppl): S127-S130
(check this in PDF content)
20
Fox CS, Larson MG, Leip EP et al. Predictors of new- onset kidney disease in a community-based population. JAMA 2004; 291: 844-850
(check this in PDF content)
21
Reynolds K, Gu D, Muntner P et al. A Population-Based, Prospective Study of Blood Pressure and Risk for End-Stage Renal Disease in China. J Am Soc Nephrol 2007; 18: 1928-1935
(check this in PDF content)
22
Hsu CY McCulloch CE, Darbinian J et al. Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease. Arch Intern Med 2005; 165 (4): 923-928
(check this in PDF content)
23
Ludwig T. Uber den Zusammenhang von Herz-und Nierenkrankheiten. Berlin, Germany: August Hirschwald 1856
(check this in PDF content)
24
Mahomed FA. On chronic Bright’s disease and its essential symptoms. Lancet 1879; 76 (1): 46-57
(check this in PDF content)
25
Ruilope LM, Lahera V, Rodicio JL and Carlos Romero J. Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension 1994; 23 (1): 3-9
(check this in PDF content)
26
Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA 1996; 275 (20): 1581-1589
(check this in PDF content)
27
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage. Hypertension 2004; 44: 595-602
(check this in PDF content)
28
Borst JGG, Borst-de Geuss A. Hypertension explained by Starling’s theory of circulatory homeostasis. Lancet 1963; 30 (1): 677-682
(check this in PDF content)
29
Guyton AC, Coleman TG, Cowley AW Jr et al. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52 (4) : 584-594
(check this in PDF content)
30
Guyton AC. Renal function curve: A key to understanding the pathogenesis of hypertension. Hypertens 1987; 10: 1-6
(check this in PDF content)
31
Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 1975; 36 (5) : 692-696
(check this in PDF content)
32
Fox U, Bianchi G. The primary role of the kidney in causing blood pressure difference between the Milan hypertensive strain (MHS) and normotensive rats. Clin Exp Pharmacol Physiol 1976; 3 [Suppl. 3]: 71-74
(check this in PDF content)
33
Kawabe K, Watanabe TX, Shiono K, Sokabe H. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing F1 hybrids. Jpn Heart J 1978; 19 (7): 886-894
(check this in PDF content)
34
Curtis JJ, Luke RG, Dustan HP et al. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009-1014
(check this in PDF content)
35
Keller G, Zimmer G, Mall G et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108
(check this in PDF content)
36
Brenner BM, Garsia DL, Anderson S. Glomeruli and blood pressure. Less of one, more of the other? Am J Hypertens 1988; 1: 335-347
(check this in PDF content)
37
Lifton RP Molecular genetics of human blood pressure variation. Science 1996; 272: 676-680
(check this in PDF content)
38
Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27 (part 2): 481-939
(check this in PDF content)
39
Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomised controlled trials. JAMA 1996; 275: 1590-1597
(check this in PDF content)
40
Каюков ИГ, Есаян АМ, Кучер АГ, Ермаков ЮА. Роль функционально-гемодинамических механизмов в прогрес­ сировании хронического гломерулонефрита. Нефрология 1998; 2 (1): 7-14
(check this in PDF content)
41
Guidi E, Bianchi G, Rivolta E et al. Hypertension in man with a kidney transplant: Role of familial versus other factors. Nephron 1985; 41: 14-21
(check this in PDF content)
42
Schmid M, Meyer S, Wegner R, Ritz E. Increased genetic risk of hypertension in glomerulonephritis? J Hypertens 1990; 8: 573-577
(check this in PDF content)
43
Fagerudd JA, Tarnow L, Jacobsen P et al. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 1998; 47: 439-444
(check this in PDF content)
44
Strojek K, Grzeszczak W, Morawin E et al. Nephropathy of type II diabetes: Evidence for hereditary factors? Kidney Int 1997; 51: 1602-1607
(check this in PDF content)
45
Sealey JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991; 37: 1811-1819
(check this in PDF content)
46
Mattson DL, Maeda CY, Bachman TD, Cowley AW Jr. Inducible Nitric Oxide Synthase and Blood Pressure. Hypertension 1998; 31: 15-24
(check this in PDF content)
47
Johnson RJ, Herrera-Acosta J, Schreiner GF et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346 (12): 913-923
(check this in PDF content)
48
Goldblatt H. The renal origin of hypertension. Physiol Rev 1947; 27: 120-132
(check this in PDF content)
49
Moritz AR, Oldt MR. Arteriolar sclerosis in hypertensive and nonhypertensive individuals. Am J Pathol 1937; 13: 679­ 728
(check this in PDF content)
50
Серов ВВ, Яргин СВ. Морфо- и патогенез нефроск- лероза: клинико-морфолгический анализ. Тер архив 1986; 58 (8): 4-9
(check this in PDF content)
51
Мационис АЭ, Батюшин ММ, Повилайтите ПЕ, Лит­ винов АС. Морфологический анализ патологических изме­ нений в почках в зависимости от длительности артериальной гипертензии. Нефрология 2007; 11 (3): 55-59
(check this in PDF content)
52
Sommers SC, Relman AC, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 1958; 34: 685-715
(check this in PDF content)
53
Moritz AR, Oldt MR. Arteriolar sclerosis in hypertensive and nonhypertensive individuals. Am J Pathol 1937; 13: 679­ 728
(check this in PDF content)
54
Kincaid-Smith P Clinical diagnosis of hypertensive nephrosclerosis. Nephrol Dial Transplant 1999; 14: 2255-2256
(check this in PDF content)
55
Caetano EP, Zatz R, Praxedes JN. The clinical diagnosis of hypertensive nephrosclerosis - how reliable is it? Nephrol Dial Transplant 1999; 14: 288-290
(check this in PDF content)
56
Kincaid-Smith P The prevention of renal failure. In: Villarreal H, ed. Proceedings of the Fifth International Congress of Nephrology Mexico. S. Karger, Basel 1972: 100-118
(check this in PDF content)
57
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic (The antihypertensive and lipid lowering treatment to prevent heart attack trial - ALLHAT). JAMA 2002; 288: 2981-2997
(check this in PDF content)
58
Luke RH. Hypertensive nephrosclerosis: pathogenesis and prevalence. Nephrol Dial Transplant 1999; 14: 2271-2278
(check this in PDF content)
59
Мухин НА, Балкаpов ИМ, Соничев ДГ, Лебедева МВ. Фоpмиpование аpтеpиальной гипеpтонии пpи уpатном тубулоинтеpстициальном поpажении почек. Тер архив 1999; 71 (6): 23-29
(check this in PDF content)
60
Kanellis J, Nakagawa T, Herrera-Acosta J et al. A single pathway for the development of essential hypertension. Cardiol Rev 2003; 11: 180-196
(check this in PDF content)
61
Kimmelsteil P, Wilson C. Benign and malignant hypertension and nephrosclerosis. A clinical and pathological study. Am J Pathol 1936; 12: 45-81
(check this in PDF content)
62
Sommers SC, Relman AC, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 1958; 34: 685-715
(check this in PDF content)
63
Sommers SC, Melamed J. Renal pathology of essential hypertension. Am J Hypertens 1990; 3: 583-587
(check this in PDF content)
64
Jones DB. Arterial and glomerular lesions associated with severe hypertension. Lab Invest 1974; 31: 303-313
(check this in PDF content)
65
Gymez DM. Evaluation of renal resistances, with special
(check this in PDF content)